UM
ZBH icon

UniSuper Management’s Zimmer Biomet ZBH Stock Holding History

UniSuper Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
18,170
-6,774
-27% -$594K 0.01% 460
2026
Q1 		$2.26M Sell
24,944
-1,088
-4% -$99.8K 0.01% 441
2025
Q4 		$2.34M Sell
26,032
-4,139
-14% -$392K 0.01% 443
2025
Q3 		$2.97M Buy
30,171
+4,568
+18% +$453K 0.02% 400
2025
Q2 		$2.34M Buy
25,603
+1,578
+7% +$153K 0.02% 433
2025
Q1 		$2.72M Buy
24,025
+242
+1% +$25.9K 0.02% 376
2024
Q4 		$2.51M Buy
23,783
+4,213
+22% +$452K 0.02% 387
2024
Q3 		$2.11M Buy
19,570
+1,852
+10% +$202K 0.02% 414
2024
Q2 		$1.92M Buy
17,718
+7,761
+78% +$915K 0.02% 399
2024
Q1 		$1.31M Buy
9,957
+7,891
+382% +$986K 0.01% 382
2023
Q4 		$251K Sell
2,066
-1,066
-34% -$119K ﹤0.01% 465
2023
Q3 		$351K Sell
3,132
-375
-11% -$47.6K ﹤0.01% 365
2023
Q2 		$511K Buy
+3,507
New +$477K 0.01% 315

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UniSuper Management's ZBH Position: Q2 2026 in Review

UniSuper Management reduced its Zimmer Biomet (ZBH) stake by 27% in Q2 2026, selling an estimated $594K and leaving 18,170 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #460.

UniSuper Management first reported a position in ZBH in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.97M in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • UniSuper Management held 18,170 shares of Zimmer Biomet worth $1.56M as of Q2 2026.
  • UniSuper Management sold 6,774 Zimmer Biomet shares in Q2 2026, an estimated $594K.
  • Zimmer Biomet made up 0.01% of UniSuper Management's portfolio in Q2 2026, its #460 holding.
  • UniSuper Management first reported a position in Zimmer Biomet in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Zimmer Biomet position peaked at $2.97M in Q3 2025.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.